Objective: The aim of this study was to determine the effectiveness of buni-berry (Antidesma bunius) extract to increase PON1 mRNA expression in BALB/c mice fed with a high-fat diet. Methods: Twenty, thirty-weeks old male BALB/c mice were randomly allocated into four intervention groups; buni berry extract, simvastatin, control-sick and control-normal groups. All groups received high fat diet, except control-normal group which received control normal-diet. The diets were provided for 12 weeks. Treatments were started in all groups at the same time with the administration of the diets. Mice in buni-berry group were treated with oral buni-berry 300 mg/kgBW/day. In simvastatin group the mice were provided with oral simvastatin 6 mg/kkBW/day. The mice in control-sick and control-normal group were not received additional treatment. The intervention was conducted in 12 weeks. Mice body weight was measured weekly. Blood samples from tails were examined at the baseline and after12 weeks intervention for PON1 mRNA expression.
INTRODUCTION
Berries are known as fruits with high anthocyanins content and other polyphenolic compounds that is associated with cardiovascular disease prevention. 1 Phenolic compounds in berries particularly anthocyanins were found to be effective in the reduction of atherosclerosis process that causes coronary heart disease through inhibition of LDL oxidation and increases HDL efflux. 2, 3 Buni -berries (Antidesma bunius) is a berry-fruit that is native to Southeast Asia and Northern Australia. The fruit in Indonesia is known as buni, whoonee, bunne and many other traditional names. The dark-purple ripe fruits are rich in phenolic compounds particularly flavonoid anthocyanins and high antioxidant capacity. 4, 5 Paraoxonase 1 (PON1) is an HDL associated enzyme , that has recently drown researchers attention on its roles on the prevention of the development and process of atherosclerosis. 6 Studies by Litvinov et al. 7 and Lusis et al. 8 have revealed that PON1 as protein and hydrolyzing enzyme responsible for the most of the antioxidant properties of HDL which prevent LDL and HDL from oxidation. Martini et al. 9 reported in their review that polyphenolic compounds from fruits and other part of plants can increase expression of PON1 mRNA and concentration of PON1 enzyme. The aim of our study was to demonstrate whether buni-berry (Antidesma bunius) extract can increase mRNA expression of PON1 in balb/c mice fed with a high-fat diet.
MATERIALS AND METHODS

Animals
Male BALB/c mice aged 6 weeks (15-20 gr) were obtained from Unit Maintenance and Development of Animal Trial Molecular Biology and Immunology Laboratory Faculty of Medicine, Hasanuddin University, Makassar. All the mice were caged in groups of six under environmentally controlled room with 12 h light/dark cycle and provide standard rodent diet and water ad libitum until further 30 weeks of age. The 30 weeks old mice were then randomly allocated into the four experiment groups that matched for body weight (Table 3) .
Diets
Standard diet (control diet) D12102 and high fat diet Clinton/Cybulsky D12109 used, were purchased from Research Diet Inc. USA. The control diet D12102 contained 10% calory from fat. The high fat diet contained 40% calory from fat mainly from cocoa butter with 1.25% cholesterol (w/w) Anthocyanin-rich Buni-berry (Antidesma bunius) Extract Increases Paraoxonase 1 Gene Expression in BALB/c Mice Fed with a High-fat Diet and 0.5% cholic acid (w/w). 10 The detail composition of the diets used is presented in Table 1 .
Plant material
Overriped, black purple A. bunius were obtained from local farm in District of Malino, South Sulawesi, Indonesia. The berries were then cleaned, washed and packaged in plastic bags and store in freezer at -20 o C until used.
Chemicals and Drugs
Deionized-water was purchased from OneMed Laboratories Inc. Indonesia. Ascorbic, citric and gallic acid, Folin-Ciocalteau reagent, methanol, ethanol, acetone, sodium carbonate, potassium chloride, sodium acetate, 1,1-diphenyl-2-picrylhydrazyl (DPPH) were procured from Merck, Germany. Sodium carboxymethyl cellulose, ethylene-diamine-tetra-acetic acid (EDTA) and Tris-HCl were obtained from Sigma Aldrich, Switzerland. Guanidium thiocyanate was from Fluka Chemie, Switzerland. TritonX-100 was from Roche, Germany. Celite was purchased from Jansen Chimica, Belgium. Enzyme Superscript II reverse transcriptase was purchased from Invitrogen, USA. SYBR Green qRT-PCR Supermix was purchased from Bio-Rad, USA. Simvastatin was obtained from Kimia Farma, Pharmaceuticals, Indonesia. All other chemicals were of analytical grade.
Preparation of buni-berry (Antidesma bunius) extract
The frozen berries were then extracted with a 70% ethanol acidified with 0.01% citric acid at pH of 4.9 and put in a room with temperature of 26°C for about 6 hrs. 11 The extracts were then filtered on Whatman 415 paper and concentrated using vacuum rotary evaporator (Buchi, Switzerland) until all alcoholic residues were removed.
Buni-berry extract analysis Total phenols
The extract then was analysed for total phenolic content using FolinCiocalteu method. 12 Briefly, A volume of 0.5 mL of the extract (100 µg/mL) was mixed with 2 mL of the Folin-Ciocalteu reagent (diluted 1:10 with de-ionized water) and were neutralized with 4 mL of sodium carbonate solution (7.5%, w/v). The reaction mixture was incubated at room temperature for 30 min. The absorbance was measured at 765 nm. The total phenolic contents were determined from the linear equation of a standard curve prepared with gallic acid. The content of total phenolic compounds expressed as mg/g gallic acid equivalent (GAE) of extract.
Total anthocyanins
Total anthocyanins content (TAC) of the buni-berry extract was measured using pH differential method. 13 Two samples of extract were weighed to 0.05 g each. The first sample was mixed with 0.025 M potassium chloride buffer (pH 1.0) and the other sample with 0.4 M sodium acetate buffer pH 4.5. Following 2 hrs of incubation at room temperature (~25°C), the absorbance for each sample was then read versus the buffer solution pH 1.0 and buffer solution pH 4.5 as the blank at λ = 510 nm (for the cyanidin 3-glucoside) and λ= 700 nm (for correction factor). The absorbance values were calculated using the equation: A= {(A516-A700) pH 1 − (A516-A700) pH 4.5} TAC was expressed as cyanidin-3-glucoside (% w/w) equivalents, as follows:
where, A= absorbance value; MW (molecular weight) = 449.2 g.mol −1 for cyanidin-3-glucoside (cyd-3-glu); DF = dilution factor; V= final volume after dilution; W = sample weight (mg); l = width of the cuvette (cm); ε = 26,900 M extinction coefficient in L mol −1 cm −1 for cyd-3-glu.
Antioxidant capacity
The antioxidant capacity of buni-berry extract and of the standard solution (ascorbic acid) were measured using 1,1,-diphenyl-2-picrylhydrazyl (DPPH) method. 
Statistical Analysis
The results are presented as mean ± SD (standard deviation). The differences between groups are analysed using paired t-test or ANOVA with p-value less than 0.05 is considered significant
Ethics Statement
The animals were treated following the principles and protocols of The Declaration of Helsinki. 
RESULTS
The Extract Profiles
The concentration of total phenolic compounds is 3.42 % and total anthocyanins is 0.83% (Table 2) . It means, the extract contained not only anthocyanin, but also other polyphenolic compounds that made up to 3.42%. The extract showed the ability to neutralize free radicals with antioxidant capacity of 56.46 ppm in term of IC 50 (Table 2) . Inhibition concentration 50 (IC 50 ) means that the minimal concentration of the extract that can neutralize at least 50% of the free radicals of 1, 1-diphenyl-2-picrylhydrazyl (DPPH). IC 50 of less than 50 ppm is considered as very strong antioxidant capacity, while between 50 to 100 ppm is considered strong.
The mice body weight
During 12 weeks intervention the mortality rate of the BALB/c mice was 2/28. The average weight of mice at the initial intervention and the change of body weight during intervention in four different groups were not significantly different (Table 3) .
Expression of PON1 mRNA
The mRNA expression of PON1 enzyme significantly increased in buni berries extract group and simvastatin group (Table 4) . On the other hand the expression of PON1 mRNA reduced in the group that was fed with a high fat diet without any intervention (control-sick). In the normal diet (control-normal) group, there was not any significant change in the mRNA expression of paraoxonase 1 (PON1) enzyme.
The concentration of sample required to neutralize 50% of DPPH (IC 50 ) was determined using the curve of percent inhibitions plotted against the respective concentration.
Intervention
After acclimatization for the new environment (individual cage and new diets), the 30 weeks male BALB/c mice were randomly allocated to four intervention groups with matched body weight.
(1) Buni-berry extract (treatment), (2) Simvastatin (control positif), (3) Control sick and (4) Control normal. Each intervention group consisted of five mice. The mice in the first three intervention groups were fed with a high-fat diet (D12109C), while the mice in control-normal group were fed with control diet (D12102C). The intervention was conducted for 12 weeks as follows: Every mouse was put in a different individual cage and had free access to diet provided and drinking water. Each mouse in the buni-berry extract group and the simvastatin group respectively received buni-berry extract 300 mg/kgBW/day 15 and simvastatin 6 mg/KgBW/day, 16 Each, the extract and simvastatin was separately dissolved in sodium carboxymethyl cellulose 5% solution and delivered orally using ball tip needle to avoid damage in the esophagus or passing through the respiratory tract. In the control-sick group and control-normal group, the mice did not received additional intervention except the high-fat diet and controlnormal diet, respectively. All mice were weighted weekly, provided and leftover food weighted daily. Blood samples were withdrawn from mouse's tail at baseline (before the intervention was started) and from cardiac puncture at the end of the intervention.
Nucleic acid extraction
Extraction of nucleid acid was extracted according to the protocol of previous study. 17 Briefly, lysing, binding and washing were three main steps of this method. One hundred µl of blood sample was dissolved into "L6" solution which is developed from 120 g guanidiun thyocianate in 100 mL 0.1 M Tris-HCl pH 6.4, 22 mL EDTA pH 8.0 and 2.6 g Triton X-100. After lysing process the nucleid acid was bound to celitein 50 mL H 2 O and 500 µL of 32% (w/v). The solution then was vortexed and centrifuged in effendorf tube 1.5 ml at 13,000 for 15 sec. The supernatant was discarded and the sediment left then was washed with 1 ml "L2" solution (guanidium thyocianate and Tris HCl pH 6.4). The mixture then was vortexed and centrifuged at 13,000 rpm for 15 sec, this washing process was repeated twice and continued with 1 mL ethanol 70% twice and the last with 1 mL acetone. The result then was incubated in a water-bath at The following forward and reverse primer were used for PON1: TTCCTTTGTACACAGCAGCG and TGCTGGCTCACAGATTTC respectively 18 For housekeeping gene β-actin forward primer was CTCTGGCTCCTAGCACCATGAAGA and reverse primer was GTAA AACGCAGCTCAGTAACAGTCCG. [19] [20] cDNA templates for use in real time PCR were synthesized from 5 μg of total RNA by in vitro transcription in 20 μl reaction containing 0.5 μg Oligo (dT), 10 μM dNTPs and *Values are means ±SD n = 5 , p-value < 0.05 is considered significant; a=p-value of the different of means body weight at baseline across four intervention groups using ANOVA; b= p-value of the different of means body weight at 12 weeks intervention using ANOVA; c,d,f,g = p-value of the different of means body weight between baseline and 12 weeks intervention using paired t test. 
DISCUSSION
The anthocyanins and total phenolic content of 0.83% and 3.42% respectively, is in accordance with previous reports by Butkhup and Samappito. 4 The buni-berry extract that was used in this study contains anthocyanins and other polyphenolic compounds. As what have been reported by previous studies, anthocyanins and other polyphenolic compounds from fruit demonstrated the ability to prevent atherosclerosis process through improving the expressions and concentrations of markers associated with atherosclerosis process. 2, 3 The present study shows that buni berry extract significantly increased paraoxonase (PON1) mRNA expression. Our study result supports the finding of previous research by Kivici et al. using different fruit extract. 20 The research demonstrated that the administration of grape seed extract (GSE) at the dose of 100 mg/kgBW/day, orally, in streptozotocin-induced diabetic rat, for six weeks caused a significant increase in PON1 activitiy compared to the diabetic mice without GSE supplementation. Furthermore, more recent study by Estrada-Luna et al. also reported that another kind of fruit juice (pomegranate juice) supplementation at the dose of 300 µl/ day that contained 0.35 mmol polyphenols, orally in mice fed with a high fat diet for five months, resulted in the increase expression aand activity of PON1. 21 In contrast, El-Beshbishy et al. 22 failed to demonstrate a modulation on serum PON1 activity in rats supplemented with Morus alba (Egyptian mulberry) root bark extract at the dose of 500 mg/kg/day for 2 weeks. However, the positive result from the study is that the extract protected LDL from oxidation. This might be a direct effect of polyphenols on LDL itself and was not mediated by PON1 activity. Schrader et al. 23 also reported that diet enriched with an isoflavone compound, genistein (2 g/ kg diet) which was provided for three weeks to male Wistar rats did not increase PON1 activity. The contrary results from the two studies may be because of the short duration of the intervention. The effect of polyphenols on PON expression and activity could effectively be detected if the duration of the intervention is at least 12 weeks. 9 In our study, the effect that was resulted from the buni berry extract on PON1 expression was comparable to those with simvastatin, a typical lowering cholesterol drug. Statins modulate expression of PON1 gene through the interaction of sterol regulatory element binding protein (SREBP-2) with Sp1 24 and mitogen-activated protein kinase (MAPK) signaling cascade. 25 Paraoxonase 1 is an HDL associated enzyme that is believed to have the major role in the prevention of atherosclerosis process. 6, 7 Polyphenolic compounds in the buni berry extract mainly anthocyanins and other polyphenolic compounds might be responsible for the effect to increase expression of PON1 mRNA. Several study in animals and human have provided evidences that polyphenolic compounds from several different fruit and plant components have increased PON1 mRNA expression and PON1 concentration. 9 In daily life, free radicals from internal body metabolisms and from outer environments can cause lipid oxidation as the initial process of atherosclerosis. PON 1 enzyme as a protein component of HDL prevents HDL and LDL from oxidation. 6 Through research, pathways have been postulated to explain how polyphenolic compounds can increase the expression of PON1 mRNA. Gouedard et al. showed that PON1 gene expression increased by an aryl hydrocarbon receptor-dependent mechanism, 26 whereas study by Khateeb et al. reported that pomegranate juice increased PON1 expression through PPAR-γ pathway. 27 Another result from our study is that, mice feed with a high fat diet without any other intervention showed a very significant reduction in the expression of PON1 expression. This result is in agreement with the research conducted by Thomas-Moya et al. in whistar rat which showed that a high fat diet reduced the expression of PON1 mRNA and activity. 28 Another research also reported that pro-atherosclerotic diet in rabbit reduced PON1 activity. 29 The novelty of our research is that, it was the first intervention study that utilized the potential benefit of buni-berry (Antidesma bunius) extract in prevention of atherosclerosis process through increasing PON1 expression as an HDL associated enzyme which has the major roles in prevention and retarding lipid oxidation process. The limitation of our study is that, the intervention was performed in animal model, therefore, further research in human is recommended to determine the actual benefit of the buni-berry (Antidesma bunius) extract in prevention and retarding atherosclerosis process.
CONCLUSION
Oral administration of 300 mg buni-berry (Antidesma bunius) extract per kg body-weight per day in 12 consecutive weeks effectively increases PON1 expression in BALB/c mice fed with a high-fat diet. Our result supports previous evidence that fruit extract with anthocyanin content and other polyphenolic compounds might effectively be used to prevent and decelerate atherosclerosis process through promoting PON1 mRNA expression and activity as an HDL associated enzyme which contributes to the prevention of lipid oxidation as the initial process of atherosclerosis. Further trials in human are needed to strengthen the evidence.
